- Home
- CHR vs GOVX Comparison
CHR vs GOVX Comparison
Compare CHR & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- GOVX
- Stock Information
- Founded
- CHR 2016
- GOVX 2001
- Country
- CHR China
- GOVX United States
- Employees
- CHR N/A
- GOVX N/A
- Industry
- CHR EDP Services
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- GOVX Health Care
- Exchange
- CHR Nasdaq
- GOVX Nasdaq
- Market Cap
- CHR 26.1M
- GOVX 23.8M
- IPO Year
- CHR N/A
- GOVX N/A
- Fundamental
- Price
- CHR $2.60
- GOVX $2.26
- Analyst Decision
- CHR
- GOVX Strong Buy
- Analyst Count
- CHR 0
- GOVX 5
- Target Price
- CHR N/A
- GOVX $14.20
- AVG Volume (30 Days)
- CHR 261.7K
- GOVX 715.7K
- Earning Date
- CHR 07-31-2024
- GOVX 11-12-2024
- Dividend Yield
- CHR N/A
- GOVX N/A
- EPS Growth
- CHR N/A
- GOVX N/A
- EPS
- CHR 3.44
- GOVX N/A
- Revenue
- CHR $155,947,000.00
- GOVX $3,090,161.00
- Revenue This Year
- CHR N/A
- GOVX N/A
- Revenue Next Year
- CHR N/A
- GOVX $150.51
- P/E Ratio
- CHR $0.76
- GOVX N/A
- Revenue Growth
- CHR 0.88
- GOVX N/A
- 52 Week Low
- CHR $2.18
- GOVX $1.09
- 52 Week High
- CHR $3.90
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- CHR 41.85
- GOVX 44.80
- Support Level
- CHR $2.69
- GOVX $2.17
- Resistance Level
- CHR $3.10
- GOVX $2.50
- Average True Range (ATR)
- CHR 0.24
- GOVX 0.17
- MACD
- CHR -0.02
- GOVX -0.04
- Stochastic Oscillator
- CHR 10.53
- GOVX 18.33
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.